NO20050215L - Nesepreparater omfattende mucopolysakkarid og propylenglykol - Google Patents

Nesepreparater omfattende mucopolysakkarid og propylenglykol

Info

Publication number
NO20050215L
NO20050215L NO20050215A NO20050215A NO20050215L NO 20050215 L NO20050215 L NO 20050215L NO 20050215 A NO20050215 A NO 20050215A NO 20050215 A NO20050215 A NO 20050215A NO 20050215 L NO20050215 L NO 20050215L
Authority
NO
Norway
Prior art keywords
mucopolysaccharide
propylene glycol
nose
preparations
nose preparations
Prior art date
Application number
NO20050215A
Other languages
English (en)
Inventor
Giovanna Marzano
Urbano Salvi
Isabelle Rault
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Publication of NO20050215L publication Critical patent/NO20050215L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er beskrevet farmasøytiske preparater tilpasset for neseadministiering. Nesepreparatene ifølge oppfiimelsen er kjeimetegnet ved at de blant annet har utmerkede fiiktende egenskaper og ikke krever et konserveringsmiddel.
NO20050215A 2002-06-20 2005-01-13 Nesepreparater omfattende mucopolysakkarid og propylenglykol NO20050215L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02013693 2002-06-20
PCT/EP2003/006478 WO2004000272A1 (en) 2002-06-20 2003-06-18 Nasal compositions comprising a mucopolysaccharide and propylene glycol

Publications (1)

Publication Number Publication Date
NO20050215L true NO20050215L (no) 2005-01-13

Family

ID=29797130

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050215A NO20050215L (no) 2002-06-20 2005-01-13 Nesepreparater omfattende mucopolysakkarid og propylenglykol

Country Status (12)

Country Link
US (1) US20050129622A1 (no)
EP (1) EP1517673A1 (no)
JP (1) JP2005533076A (no)
AR (1) AR039703A1 (no)
AU (1) AU2003278962B2 (no)
CA (1) CA2489528A1 (no)
NO (1) NO20050215L (no)
NZ (1) NZ537186A (no)
PL (1) PL373033A1 (no)
RU (1) RU2005101331A (no)
TW (1) TW200402307A (no)
WO (1) WO2004000272A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100518152B1 (ko) * 2002-05-09 2005-09-29 메디제네스(주) 혈장 또는 혈청을 함유한 창상 치료용 약학 조성물
JP2005075735A (ja) * 2003-08-28 2005-03-24 Rohto Pharmaceut Co Ltd オキシメタゾリン含有組成物
DE20318634U1 (de) 2003-11-13 2004-02-26 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
FR2901705A1 (fr) * 2006-06-01 2007-12-07 Persee Medica Soc Par Actions Composition pour lutter contre le ronflement se presentant sous la forme d'un spray nasal
FR2901706A1 (fr) * 2006-06-01 2007-12-07 Persee Medica Soc Par Actions Compositions nasale et buccale pour lutter contre le ronflement
DE102007006122A1 (de) * 2007-02-02 2008-08-07 Krewel Meuselbach Gmbh Cistusextrakte
US20120225918A1 (en) * 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
ITMI20110558A1 (it) * 2011-04-06 2012-10-07 Campiglio Consulting Srl Composizione farmaceutica contenente ciclobenzaprina adatta alla somministrazione endonasale
SG10201913330SA (en) * 2013-09-11 2020-03-30 Glenn Abrahmsohn Hypertonic antimicrobial therapeutic compositions
WO2019049145A1 (en) * 2017-09-11 2019-03-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. COMPOSITIONS AND METHODS FOR NASAL BRAIN MEDICATION ADMINISTRATION FOR SYSTEMIC EFFECT

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945636A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung
US4402949A (en) * 1979-11-12 1983-09-06 Sandoz Ltd. Stable solutions of hydrogenated ergotalkaloids
AU655919B2 (en) * 1990-02-22 1995-01-19 Macnaught Pty Limited Artificial tears
IT1273742B (it) * 1994-08-01 1997-07-09 Lifegroup Spa Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
JPH10231243A (ja) * 1997-02-20 1998-09-02 Sekisui Chem Co Ltd 粘膜炎症外用薬
EP0979105A1 (en) * 1997-04-30 2000-02-16 Warner-Lambert Company Topical nasal antiinflammatory compositions
JPH1179994A (ja) * 1997-09-08 1999-03-23 Ikeda Mohandou:Kk 点鼻適用製剤
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
EA200000439A1 (ru) * 1997-10-22 2000-12-25 Йенс Поникау Способы и материалы для лечения и профилактики воспаления ткани слизистой оболочки
US20010053775A1 (en) * 1998-01-30 2001-12-20 Matthias Seidel Nasal solutions
JP4603687B2 (ja) * 1998-01-30 2010-12-22 ノバルテイス・コンシユーマー・ヘルス・エス・アー 点鼻用液剤
US6193997B1 (en) * 1998-09-27 2001-02-27 Generex Pharmaceuticals Inc. Proteinic drug delivery system using membrane mimetics
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
IL147023A0 (en) * 1999-06-22 2002-08-14 Boehringer Ingelheim Int Stable xylometazoline and oxymetazoline solution
JP2001072605A (ja) * 1999-09-03 2001-03-21 Lion Corp 経皮経粘膜吸収促進剤組成物
US20030086899A1 (en) * 2000-03-14 2003-05-08 Jafari Masoud R. Chondroitin sulfate containing viscoelastics for use in treating joints
WO2002024116A1 (en) * 2000-09-20 2002-03-28 Shahinian, Lee, Jr. Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US20040235807A1 (en) * 2003-05-21 2004-11-25 Weinrich Karl P. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea

Also Published As

Publication number Publication date
AU2003278962A1 (en) 2004-01-06
US20050129622A1 (en) 2005-06-16
WO2004000272A1 (en) 2003-12-31
RU2005101331A (ru) 2006-01-20
AU2003278962C1 (en) 2004-01-06
CA2489528A1 (en) 2003-12-31
AR039703A1 (es) 2005-03-09
TW200402307A (en) 2004-02-16
JP2005533076A (ja) 2005-11-04
AU2003278962B2 (en) 2006-11-23
PL373033A1 (en) 2005-08-08
EP1517673A1 (en) 2005-03-30
NZ537186A (en) 2006-10-27

Similar Documents

Publication Publication Date Title
NO20050215L (no) Nesepreparater omfattende mucopolysakkarid og propylenglykol
HU230005B1 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
IL258702B (en) Pump system for use in organ treatment systems
BR0115810B1 (pt) composições cosméticas, dermatológicas e farmacêuticas isentas de tensoativos.
LU91144B1 (fr) Vérification biométrique sécurisée de l'identité.
BR0210139A (pt) Composições farmacêuticas
WO2004021968A3 (en) Solution for ungual application
WO2003061558A3 (en) Glycoconjugate vaccines for use in immune-compromised populations
NO20082376L (no) Farmasoytiske sammensetninger
WO2006118884A3 (en) Drug delivery devices and related components, systems and methods
BR0308486A (pt) Composição tópica compreendendo um ciclofrutano, um veìculo e uma droga
EP3936150A4 (en) ANTIBODY-DRUG CONJUGATES COMPRISING ANTIBODY AGAINST HUMAN DLK1 AND USE THEREOF
WO2007027314A3 (en) Anti-inflammatory compositions and methods of use
BR0314058A (pt) Composições para cuidados pessoais a base de álcool ramificado
DE50213839D1 (de) Dünnflüssige, sprühbare w/o emulsionen
RS50591B (sr) Lek za lečenje gljivičnih infekcija, naročito aspergiloze
BR0305411A (pt) Poliisocianatos contendo grupos uretodiona pobres em monÈmeros
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
ES1053382Y (es) Protesis dilatadora del vestibulo nasal.
TR200103723T2 (tr) Dayanıksız terkipler, özellikle kozmetik ve farmasötik terkipler için koruyucular
WO2003105751A3 (en) NEW CURCUMIN DERIVATIVES
MY139425A (en) Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol
DK1537065T3 (da) Analoger af D-vitamin
AU2003219046A1 (en) Cationic polymers and the use thereof in cosmetic formulations
WO2006052603A3 (en) Modular building system and componentry

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application